Keyword [dual target]
Result: 61 - 80 | Page: 4 of 5 |
| 61. | Design,Synthesis And Antitumor Activity Screening Of ALK/EGFR Dual-target Inhibitors |
| 62. | Design, Synthesis And Activity Screening Of α-substituted 1,3-diketone P53-MDM2/MDMX Dual-Target Inhibitors |
| 63. | Design And Synthesis Of Dual GPR119/DPP-4 Modulators Bearing Tetrahydropyridopyrimidine For Treatment Of Type 2 Diabetes |
| 64. | Study Of Antitumor Effects Of HDAC/Tubulin Dual Target Inhibitor B8HA On Breast Cancer Cell In Vitro And In Vivo |
| 65. | Study On Screening And Anti-leukemia Effects Of Indole HDAC6/Tubulin Dual Target Inhibitors |
| 66. | Design And Synthesis Of Dual-target Drugs Based On PSD95-nNOS Uncouplers |
| 67. | Study On The Anti-neuroinflammatory Effect Of A Novel Phosphodiesterase 4/5 Dual-target Inhibitor |
| 68. | Design,Synthesis And Biological Evaluation Of JAK2,FLT3 And Dual-target Inhibitors For The Treatment Of Myeloid Malignancies |
| 69. | Discovery Of Thieno[2,3-d]pyrimidine Based Dual Target Drugs Against Carcinoma In Vitro And In Vivo |
| 70. | Design,Synthesis And Biological Evaluation Of EGFR/HER2 Dual-Target Inhibitors |
| 71. | Design,Synthesis And Activity Study Of PARP/HDAC Dual Target Inhibitors |
| 72. | Experiment Of Dual-target Molecular Probe 68Ga-DOTA-exendin-4-TOC For Neuroendocrine Neoplasms Imaging |
| 73. | Prognostic Analysis Of Dual-Target Therapy For Advanced Breast Cancer And Correlation Study Of ESR And CRP |
| 74. | Design,Synthesis And Preliminary Biological Evaluation Of BTK/HDAC Dual Target Inhibitors |
| 75. | Design,Synthesis,and Biological Evaluation Of APN And AKT Dual-target Inhibitors |
| 76. | Design,synthesis And Biological Evaluation Of Dual Target Inhibitors Of P53-MDM2/MDMX Based On Pyrrolidone Scaffold |
| 77. | Design,Synthesis And Bioactivity Evaluation Of Indoline Piperidine Amides As Novel MOR Agonist/TRPV1-Antagonist Dual-Target Compouds |
| 78. | Design,Synthesis And Anti-NSCLC Activity Of Novel 4-phenoxyquinazoline EGFR/c-Met Dual Inhibitors |
| 79. | Effect Of Two Neoadjuvant Chemotherapy Regimens Combined With Dual-target On HER-2 Positive Breast Cancer And Its Related Factors Analysis |
| 80. | The Antitumor Activity And Mechanisms Of A Novel EGFR/VEGFR Dual Target Inhibitor IRM-39 And Radiotherapy On Non-small Cell Lung Cancer |
|
